Chronic Traumatic Encephalopathy (CTE) is a brain disease associated with repeated head injuries or impacts. It has been particularly observed in people who have experienced repeated blows to the head through sports or other activities.
The Difficulty of Diagnosing CTE
At present, a definite diagnosis of CTE can only be made after death by examining brain tissue. In living people, doctors generally consider a person’s history of repeated head injuries and symptoms while also trying to rule out other possible conditions.
For this reason, researchers are looking for a reliable test that could identify CTE while a person is still alive.
What Does the New Research Show?
A report published in 2026 highlighted the importance of finding new biomarkers—biological signs that may help identify the disease. Researchers are studying possible biomarkers found through brain imaging, blood tests, and other bodily fluids.
Scientists are especially studying specific changes in tau protein associated with CTE. If a reliable biomarker can be developed and validated, it could open new possibilities for diagnosing CTE in the future.
Brain Scans and Blood Tests
Research is also continuing on brain-imaging methods such as MRI and PET scans. Scientists are trying to determine whether specific changes in the brain can be linked to CTE. Researchers are also studying biomarkers in blood and cerebrospinal fluid. However, none of these methods has yet been fully proven as a definitive test for CTE.
Why Does the Research Offer Hope?
The new research is important because a reliable way to diagnose CTE during a person’s lifetime could help doctors better understand and monitor the disease and potentially develop treatments in the future. Experts consider the discovery of CTE-specific biomarkers an important next step in this field.
Conclusion
A definitive diagnosis of CTE is still possible only through examination of brain tissue after death. However, new research is advancing efforts to identify the disease in living people. Studies involving biomarkers, MRI, PET scans, and bodily fluids may eventually lead to more accurate diagnostic methods. However, experts say that more research and validation are needed before these methods can become reliable clinical tests.
